Trial results for the CONFIDENCE-AI financial education program for caregivers of individuals with Alzheimer's Disease, Dementia, and related conditions were posted on ClinicalTrials.gov on 2025-07-30, indicating a mean reduction in financial strain ranging from 3.4 to 4.7 units on a scale.
Background
Caregiving for individuals with Alzheimer's disease and other forms of dementia often imposes substantial burdens, including significant psychological financial strain and challenges in managing out-of-pocket care costs. Caregivers frequently face complex financial decisions and emotional stress, which can impact their well-being and the quality of care they provide. Interventions designed to enhance financial literacy and resourcefulness are crucial for supporting these caregivers, helping them navigate the economic complexities of long-term care and mitigate associated stress.
Trial design
This completed study, identified as Phase NA, enrolled 14 participants. The trial investigated CONFIDENCE-AI, a refined version of an original intervention, designed to reduce psychological financial strain and improve the management of out-of-pocket care costs while increasing caregiver resourcefulness skills. Participants engaged in a 4-week intervention comprising four synchronous group-based Zoom sessions and between-session activities to apply learning. Tailored text message notifications were also provided via the NeuViCare AI-powered app, allowing participants to submit questions.
Key results
The trial measured several outcomes for the CONFIDENCE-AI intervention group:
- For Financial Strain, measurements showed means of -3.4 (Standard Deviation: 4.9 units on a scale) and -4.7 (Standard Deviation: 6.6 units on a scale). The negative values suggest a reduction in financial strain.
- For Resourcefulness, measurements showed means of 13.2 (Standard Deviation: 25.7 score on a scale) and 11.3 (Standard Deviation: 13.3 score on a scale). These positive values suggest an increase in resourcefulness.
- For Self-Efficacy, measurements showed means of 16.3 (Standard Deviation: 15.2 units on a scale) and 13.2 (Standard Deviation: 10.3 units on a scale). These positive values suggest an increase in self-efficacy.
What this means
The posted results suggest that the CONFIDENCE-AI financial education program may offer tangible benefits for caregivers of individuals with Alzheimer's disease and dementia. The observed reductions in financial strain, alongside increases in resourcefulness and self-efficacy, indicate that this intervention could equip caregivers with better tools to manage the financial and psychological demands of their role. By addressing these critical areas, such programs have the potential to alleviate caregiver burden and improve their overall well-being, ultimately supporting more sustainable and effective caregiving.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT06134180, titled "CONFIDENCE-AI Financial Education for Caregivers (CONFIDENCE-AI)", were posted on 2025-07-30 on clinicaltrials.gov.